Anteris Technologies (AVR) News Today → The system that called 2023’s top 7 stocks is at it again… (From WealthPress) (Ad) Free AVR Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineThose who invested in Anteris Technologies (ASX:AVR) five years ago are up 292%finance.yahoo.com - April 12 at 1:27 AMASX 200 recoups early losses as major banks push higher, tech stocks pull backmsn.com - March 6 at 5:52 PMAnteris Technologies Ltd.wsj.com - March 6 at 5:52 PMAnteris Technologies Ltdafr.com - March 2 at 3:39 PMAnteris Technologies Full Year 2023 Earnings: Misses Expectationsfinance.yahoo.com - February 29 at 7:27 PMAnteris Technologies Ltd's (ASX:AVR) largest shareholders are retail investors with 50% ownership, institutions own 29%finance.yahoo.com - February 8 at 7:33 PMAnteris Technologies Ltd (AVR.XA)finance.yahoo.com - January 20 at 9:29 AMFDA submission looms as Artrya’s AI platform aims to capture the huge cardio diseases marketmsn.com - December 19 at 7:17 AMFDA approval for BiVACOR's artificial heart study paves further paths for heart tech innovationproactiveinvestors.com.au - November 29 at 11:14 PMAnteris Technologies Ltd AVRmorningstar.com - November 21 at 6:08 PMFIVE at FIVE AU: Mining lifts ASX; RBA minutes suggest further rate hikesproactiveinvestors.com.au - November 21 at 1:00 AMAnteris Technologies fields "excellent" 30-day haemodynamic...Anteris Technologies fields "excellent" 30-day haemodynamic...proactiveinvestors.com.au - November 20 at 8:00 PMAnteris Technologies fields "excellent" 30-day haemodynamic...proactiveinvestors.com - November 20 at 8:00 PMAnteris talks market superiority of its biomimetic TAVR valveproactiveinvestors.com - October 30 at 11:00 PMAnteris Technologies completes DurAVRTM Early Feasibility Study enrolmentproactiveinvestors.com - October 17 at 1:40 AMFIVE at FIVE AU: ASX slips and US markets stumble on higher-than-expected CPIproactiveinvestors.com.au - October 12 at 11:50 PMAnteris Technologies to present latest clinical data for DurAVR™au.investing.com - September 12 at 9:19 PMAnteris Announces Participation at the Cantor Healthcare Conference on Sept 26th 2023finance.yahoo.com - September 12 at 9:19 PMDurAVR™ THV Demonstrates Exceptional Results in Second Valve-in-Valve Casebusinesswire.com - August 14 at 6:05 AMAnteris Technologies Commences US Early Feasibility Studyfinance.yahoo.com - August 9 at 7:50 AMAnteris Technologies Commences American Depository Receipt Programfinance.yahoo.com - August 9 at 7:50 AMAnteris welcomes successful DurAVR valve-in-valve procedureproactiveinvestors.com.au - August 1 at 12:17 AMAnteris Technologies Announces First Successful Implantation of DurAVR™ THV in a Valve-in-Valve Procedurefinance.yahoo.com - July 31 at 8:46 AMAnteris Technologies’ DurAVR heart valve used in life-saving valve-in-valve procedureau.investing.com - July 30 at 10:39 PMAnteris Technologies says latest first-in-human DurAVR™ results are next-levelfinance.yahoo.com - June 14 at 4:55 PMAnteris Technologies presents first-in-human data at conference showing "excellent" haemodynamic performanceproactiveinvestors.com.au - June 10 at 3:20 PMAnteris Technologies hails "excellent" DurAVR™ THV results in new patient cohortproactiveinvestors.com - May 31 at 12:17 AMAnteris Technologies unveils encouraging FIH results from DurAVR™ heart valve studyproactiveinvestors.com - May 21 at 10:34 PMAnteris Technologies granted additional patent for novel heart valve; shares upproactiveinvestors.com - May 16 at 9:27 PMAnteris says new repair device provides another shot on goal for multi-billion dollar productfinance.yahoo.com - April 27 at 2:10 PMAnteris Technologies to diversify portfolio with novel heart valve repair deviceproactiveinvestors.com - April 19 at 12:54 AMAnteris Technologies awarded utility patent for novel transcatheter heart valve replacement technologyproactiveinvestors.com - April 11 at 10:55 PMThe smart money in medicine: the world's biggest killerproactiveinvestors.com.au - April 4 at 2:53 AMAnteris Technologies receives green light from US FDA to manufacture DurAVR™ Transcatheter Heart Valvesproactiveinvestors.com - March 26 at 11:47 PMAnteris Technologies CEO talks A$35 million raise and 2023 milestonesfinance.yahoo.com - February 16 at 5:54 PMAnteris Announces Completion of A$35 Million Capital Raise and Provides 2023 Goalpostsfinance.yahoo.com - February 15 at 12:35 PMAnteris Technologies raises A$35 million to fund clinical development of DurAVR™ THV aortic valve technologyproactiveinvestors.com - February 15 at 1:52 AMAnteris Technologies' transcatheter heart valve continues to demonstrate its potentialau.investing.com - February 8 at 8:09 PMAnteris Technologies receives FDA expanded approval for DurAVR™ EFS; raises $35 millionproactiveinvestors.com - February 8 at 8:09 PMAnteris bolsters capital management strategy on commercialisation pathproactiveinvestors.com - February 5 at 11:12 PMAnteris Technologies delivers strong 12-month results from DurAVR™ FIH studyproactiveinvestors.com - January 16 at 8:41 AMAnteris Technologies hails FDA early feasibility study approval for DurAVR™proactiveinvestors.com - December 5 at 8:41 PMAnteris Technologies Receives FDA Clearance to Initiate Early Feasibility Study for its Novel TAVR Product, DurAVR™finance.yahoo.com - November 28 at 12:22 PMAnteris Technologies higher as DurAVR™ transcatheter heart valve system receives FDA tick for early feasibility studyproactiveinvestors.com - November 27 at 9:40 PMAnteris Technologies' first in-human study shows restoration of blood flow in patients receiving DurAVR™proactiveinvestors.com - November 27 at 9:40 PMDow Futures Move Lower as Earnings Season Beginsmsn.com - October 10 at 9:41 AMAnteris Technologies boosted by $1.6 million R&D tax incentive refundproactiveinvestors.com.au - October 10 at 9:41 AMAnteris Technologies has valve world talking about 'human-like characteristics' of DurAVRproactiveinvestors.com.au - September 28 at 6:08 AMAnteris Technologies preliminary results show restoration of pre-disease blood flow compared to competing technologiesproactiveinvestors.com - September 19 at 1:29 AMAnteris Technologies Announces Presentation of First-In-Human Data for its Novel TAVR Product, DurAVR™ at the 2022 Annual TCT Congress in Bostonfinance.yahoo.com - September 13 at 9:04 AM Get Anteris Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now AVR Media Mentions By Week AVR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVR News Sentiment▼0.000.43▲Average Medical News Sentiment AVR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVR Articles This Week▼00▲AVR Articles Average Week Get Anteris Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CMXC News Today CHEOF News Today LNDZF News Today GNGBY News Today GGNDF News Today HTLZF News Today HSCSW News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:AVR) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anteris Technologies Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
